Akari Therapeutics, plc

Q4 2023 13F Holders

Symbol
AKTX
CUSIP
00972G108
Type
Equity
Class
SPONSORED ADR
Num filings
2
Total reported value, excl. options
$512 k
Manager Report Date Value ($000) Shares Option Type